KANGLITAI BIOMEDICAL (QINGDAO) CO LTD

Overview

KANGLITAI BIOMEDICAL (QINGDAO) CO LTD is an active pharmaceutical ingredient (API) supplier with 3 active FDA Type II Drug Master Files, covering CRYOPRESERVATION SOLUTION FOR NK CELLS; HUMAN CD3+ CELL DEPLETION REAGENT (FOR NK CELL PURIFICATION); NATURAL KILLER CELLS INDUCTION AND EXPANSION CULTURE KIT.

API / Drug Master Files

KANGLITAI BIOMEDICAL (QINGDAO) CO LTD holds 5 active (5 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• MSC EXPANSION AND CULTURE KITActive2026-06-16
• CENTRAL MEMORY T CELL INDUCTION AND EXPANSION CULTURE KITActive2026-04-21
• CRYOPRESERVATION SOLUTION FOR NK CELLSActive2025-12-09
• HUMAN CD3+ CELL DEPLETION REAGENT (FOR NK CELL PURIFICATION)Active2025-12-04
• NATURAL KILLER CELLS INDUCTION AND EXPANSION CULTURE KITActive2023-10-27

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to KANGLITAI BIOMEDICAL (QINGDAO) CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.